Research on a bacterial toxin first discovered in Adelaide has led to the development a new blood test for the early diagnosis of ovarian cancer – a disease which kills over 1000 Australian women and 150,000 globally each year. The new blood test has the potential to dramatically improve early detection of the disease, although […]Continue Reading ...
What is an estrogen test? An estrogen test measures the level of estrogens in the blood or urine. Estrogen can also be measured in saliva using at-home test kit. Estrogens are a group of hormones that play a key role in the development of female physical features and reproductive functions, including the growth of breasts […]Continue Reading ...
Today, the U.S. Food and Drug Administration announced that an emergency use authorization (EUA) has been issued for a rapid, single-use test for the detection of Ebola virus (Zaire ebolavirus). This is the second Ebola rapid antigen fingerstick test available under EUA, but the first that uses a portable battery-operated reader, which can help provide […]Continue Reading ...
What is a TP53 genetic test? A TP53 genetic test looks for a change, known as a mutation, in a gene called TP53 (tumor protein 53). Genes are the basic units of heredity passed down from your mother and father. TP53 is a gene that helps stop the growth of tumors. It’s known as a […]Continue Reading ...
NeuroPointDX, a division of Stemina Biomarker Discovery, today announced the commercial launch of its NPDX AA test, which identifies metabolic subtypes associated with autism spectrum disorder (ASD). The blood plasma-based test, provided through NeuroPointDX’s CLIA-certified laboratory, may be used to screen children as young as 18 months. Children who receive a positive result on the […]Continue Reading ...
An addict prepares heroin, placing a fentanyl test strip into the mixing container to check for contamination, Wednesday Aug. 22, 2018, in New York. If the strip registers a “pinkish” to red marker then the heroin is positive for contaminants. (AP Photo/Bebeto Matthews) The newest tool in the fight against opioid overdoses is an inexpensive […]Continue Reading ...
Today, the U.S. Food and Drug Administration permitted marketing of the PicoAMH Elisa diagnostic test as an aid in the determination of a patient’s menopausal status. “Diagnostic results about a woman’s menopausal status may prompt discussions about preventative care for women experiencing menopausal symptoms,” said Courtney Lias, Ph.D. director of the Division of Chemistry and […]Continue Reading ...
Credit: Iryna Inshyna/Shutterstock.com It was established a decade ago that testing for the presence of HPV – the virus that causes cervical cancer – is a better cervical screening test than the Pap smear. Yet in England, the Pap smear is still used, and it’s costing lives. Current screening for cervical cancer is done through […]Continue Reading ...
What is an AFP (alpha-fetoprotein) tumor marker test? AFP stands for alpha-fetoprotein. It is a protein made in the liver of a developing baby. AFP levels are usually high when a baby is born, but fall to very low levels by the age of 1. Healthy adults should have very low levels of AFP. An […]Continue Reading ...
What is a PKU screening test? A PKU screening test is a blood test given to newborns 24–72 hours after birth. PKU stands for phenylketonuria, a rare disorder that prevents the body from properly breaking down a substance called phenylalanine (Phe). Phe is part of proteins that are found in many foods and in an […]Continue Reading ...
The U.S. Food and Drug Administration today is warning patients and doctors, who use at-home or in-the-office medical devices to monitor levels of the blood thinner, warfarin, that certain test strips used with the devices may provide inaccurate results and should not be relied upon to adjust the drug dosage. Roche Diagnostics issued a voluntary […]Continue Reading ...
Today, the U.S. Food and Drug Administration permitted marketing, with special controls, of the 23andme Personal Genome Service Pharmacogenetic Reports test as a direct-to-consumer test for providing information about genetic variants that may be associated with a patient’s ability to metabolize some medications to help inform discussions with a health care provider. The FDA is […]Continue Reading ...
A biopsy test that helps transplant centers select kidneys for transplantation is often inaccurate, a new study has found, suggesting that reliance on the biopsy should be reduced.Continue Reading ...
A new blood test developed by University of North Carolina Lineberger Comprehensive Cancer Center researchers shows promise for tracking HPV-linked head and neck cancer patients to ensure they remain cancer-free after treatment. Researchers will present preliminary findings at the 60th Annual Meeting of the American Society for Radiation Oncology in San Antonio on Tuesday, Oct. […]Continue Reading ...
A new study has shown that by combining imaging and neuropsychological testing, one can more accurately assess the cognitive status of individuals. Cognitive decline is one of the most concerning behavioral symptoms associated with Alzheimer’s disease (AD). The ability to efficiently distinguish individuals with mild cognitive impairment (MCI) from individuals who have normal cognition (NC) […]Continue Reading ...
- Experts debate over whether gut or brain is more important in regulating appetite
- Playing on fear and fun, hospitals follow pharma in direct-to-consumer advertising
- Low-Carb Diets May Work By Boosting Calorie Burn
- Key molecule responsible for learning and memory discovered
- New blood test developed for early diagnosis of ovarian cancer
- Researchers identify molecule to fight myotubular myopathy
- Immune cells trigger OCD-like behaviour in multiple sclerosis, study finds
- Scientists equip new virus that kills carcinoma cells with protein
- Novel approach could provide painless, efficient alternative for treating eye diseases
- Protein in cell membranes of sperm plays key role in finding their way to eggs
- Parents who decline flu vaccination for their child may be exposed to limited information
- Mirati Presents Data From Ongoing Phase 2 Clinical Trial Of Mocetinostat In Combination With Durvalumab At The SITC 33rd Annual Meeting
- FDA warns of common diabetes meds’ link to dangerous genital infection
- New methods for preserving shoulder function, quality of life in breast cancer patients
- Surprising discovery about BH4 may rekindle interest in once-promising pathway
- Nabriva Therapeutics Completes Submission of New Drug Application to U.S. Food and Drug Administration for Intravenous Contepo to Treat Complicated Urinary Tract Infections
- Beating breast cancer only to die of opioid use – a sad Appalachian story
- Workplace bullying or violence linked to higher risk of cardiovascular problems
- Changes in Risk Indicators of MetS Severity Tied to T2DM Risk
- ‘Game-changing’ skin sensor could improve life for a million hydrocephalus patients